Decades of science show the super antioxidant as an effective daily supplement to support skin, cognitive and joint health and manage menstrual pain, UTIs and menopause

HOBOKEN, N.J. , May 11, 2022 /PRNewswire/ -- Women's health goals and concerns evolve and change with age. In observance of National Women's Health Month during May, experts are highlighting Pycnogenol® French maritime pine bark extract as a leading supplement for women's health throughout life. The super antioxidant is supported by a vast catalog of research demonstrating its widespread benefits for supporting skin, cognitive and joint health and managing menstrual pain, UTIs and menopause.

"Women's Health Month is a time for women to make their health and well-being a top priority. A woman's health goals and concerns will change with age and a science-backed supplement like Pycnogenol® presents an opportunity to develop a daily routine that delivers benefits throughout your life stages," says renowned natural health physician and author, Dr. Fred Pescatore .

Pycnogenol® French maritime pine bark extract is a proven, unique, standardized blend of powerful natural antioxidants. It has four basic properties that work to provide benefits to the entire body, especially for women's health. Pycnogenol® acts as a natural anti-inflammatory, supports the generation of collagen and hyaluronic acid and aids in the production of endothelial nitric oxide, which helps to dilate blood vessels.

"Early in life, especially from their late teens to early 30s, millions of women experience painful menstrual periods that can make days miserable and even make them miss school or work. Many women also experience an increased risk for developing UTIs during this time," says Dr. Pescatore.

Daily supplementation with Pycnogenol® has been shown to reduce abdominal discomfort by 80 percent and cramping by 77 percent in women experiencing troubled menstrual periods. With its antioxidant properties, Pycnogenol® is also effective at reducing infection occurrence and decreasing painful symptoms, like burning and itching when urinating, for those who suffer from urinary tract infections.

"Menopause is a condition women will experience for approximately one-third of their lifetime and perimenopause can bring agonizing symptoms years before that due to disruptive hormonal shifts," says Dr. Pescatore.

For those looking for a safe, natural alternative shown to improve perimenopausal and menopausal symptoms, including hot flushes and nightly sweating, menstrual problems, memory and concentration problems, anxiety, nervousness, sleeping problems and others, while having no impact on hormonal levels, Pycnogenol® provides a must-try option.

For perimenopausal women, studies have also shown that those who supplemented with Pycnogenol® saw a significant reduction of cardiovascular risk marker, homocysteine.

"Joint health and cognitive health are concerns women in their 50s and 60s face as mobility and cognition tend to decline with age," says Dr. Pescatore. "I often remind my patients to be proactive with your joint and cognitive health earlier in life to reduce risk and support your goals to live life more on your terms through advanced age."

Those who suffer from joint discomfort often rely on pain medication. Pycnogenol® provides a natural option that, in various studies, has shown joints were more flexible and less medication was required after supplementation. Pycnogenol® also has been shown to boost overall cognitive performance, including daily decision making and stress management, for those over age fifty-five.

To review clinical research and additional information on Pycnogenol®, visit www.pycnogenol.com. Pycnogenol® is available in more than 1,000 dietary supplements and health products worldwide.

About Pycnogenol® Pycnogenol® is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and phenolic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 40 years and has more than 450 published studies and review articles ensuring safety and efficacy as an ingredient. Today, Pycnogenol® is available in more than 1,000 dietary supplements and health products worldwide. For more information, visit www.pycnogenol.com.

About Horphag Research Horphag Research is the exclusive worldwide distributor for Pycnogenol® (pic-noj-en-all) brand French maritime pine bark extract. Pycnogenol® is a registered trademark of Horphag Research. For its patented ingredient, Pycnogenol®, Horphag Research has been awarded the Frost & Sullivan Excellence in Research Award, Nutraceutical Business & Technology Safety & Quality Award, SupplySide West Scientific Excellence Award and The American Botanical Council's Tyler Research Award. Horphag Research has the exclusive rights to market and sell Pycnogenol® worldwide and benefits from more than 40 years of scientific research assuring the safety and efficacy of Pycnogenol® as a dietary supplement.

View original content to download multimedia:https://www.prnewswire.com/news-releases/research-shows-pycnogenol-french-maritime-pine-bark-extract-is-a-key-natural-supplement-to-support-womens-health-throughout-life-301544383.html

Let's look at two stocks that boast significant upside potential, going by average price targets set by analysts on the street: Moderna (NASDAQ: MRNA) and CRISPR Therapeutics (NASDAQ: CRSP). Biotech giant Moderna fell along with the broader market in recent months. Moderna currently generates revenue from just one product: its coronavirus vaccine.

Hundreds of health care workers gathered outside a Nashville courthouse on Friday to protest the sentencing of a former Tennessee nurse facing up to eight years in prison for mistakenly causing the death of a patient

Despite the popularity of vegan and vegetarian diets, a majority of people in the U.S. still do eat meat. In fact, according to a 2021 survey from Ipsos, 9 in 10 Americans currently include meat as part of their diet. With that in mind, it won't be hard for most to spot the symptoms of a concerning health condition that's becoming more and more of a problem thanks to another rising trend. Researchers are warning that the increasing prevalence of one pest across the country could have serious con

Crispr Therapeutics said Thursday it will unveil the first data from human studies of its gene-edited lymphoma drug — and CRSP stock popped.

Less well known pain-inducing conditions include trigeminal neuralgia- often described as an electric shock shooting through the face

The pill has become an increasingly important tool in the nation’s defense against COVID-19 as mask mandates have lifted and people have returned to their non-distanced lives.

Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will host a key opinion leader (KOL) webinar on substance use disorders and withdrawal management on Thursday, May 19, 2022 at 11:00am EDT.

Stanislaus County’s daily case rate for COVID-19 infections was 8.26 per 100,000 population Tuesday, more than double the rate a month ago.

It’s expected that, after two years of multiple disruptions caused by the COVID-19 pandemic, there would be repercussions on our collective mental health. As recent research has shown, it is heavily impacting children and teens.

"It's creepy and gross. Stop that."View Entire Post ›

The Neurostar brain stimulation technology is now cleared for use in treating obsessive-compulsive disorder.

Earlier in April, the Marijuana Opportunity Reinvestment and Expungement Act (MORE) was narrowly passed by the United States House of Representatives by a vote of 220-204. Marijuana use was legal until 29 U.S. states banned it between 1916 and 1931.

The Duke of Cambridge has personally delivered a damehood to the home of Deborah James, visiting with her family to honour her campaign to raise awareness of bowel cancer.

Christie Brinkley, 68, says “It’s not about the size of your thighs,” while posing with coral to talk body positivity, health, and weight loss advice.

Top leaders of the U.S. Conference of Catholic Bishops called on the faithful to pray and fast Friday, in hopes the Supreme Court is on track to overturn the constitutional right to abortion. A recently leaked Supreme Court draft opinion suggests that a majority of the nine justices are poised to reverse the 1973 Roe v. Wade decision – a move that would allow individual states to outlaw abortion.

More than 10% of the 1,234 adult patients were in intensive care units as a disease subvariant drives new infections across the state.

Nurses from across Florida will be in Tallahassee to demand more staffing, better pay and better work conditions.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of Intersect ENT, expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.

Biogen and development partner Eisai are looking to get their next Alzheimer's drug to market using the FDA's accelerated approval pathway.

The party isn't done voting on abortion rights this year. But its members admit, with striking candor, that they can't pass anything without bigger majorities.